Jiajie Biomedical's revenue in 2024 was NT$530 million, a year-on-year increase of 61%.

jiajie
Jan 6
1 min read

Taiwan Steel Group's subsidiary, Chipstar Biomedical (4109), announced on the 8th that its December revenue was NT$61.17 million, a year-on-year increase of 147%, and its cumulative revenue for the first 12 months was NT$535.65 million, a year-on-year increase of 61%. The strong performance in December was driven by year-end promotional activities in multi-level marketing channels, marking the second-highest revenue performance of the year.

Chia-Chi Biomedical announced the launch of two new gummy health products to make nutrition and wellness more integrated into daily life: "Calendula Lutein Filled Gummy Candies" and "Probiotic Filled Gummy Candies." Both are sugar-free, coloring-free, and preservative-free. They are produced using a professional low-temperature, low-pressure process that preserves the nutrients within the filling layer. The outer layer is then completely coated with a sugar alcohol-based gummy layer, blocking air and light. This ensures both deliciousness and health benefits, allowing the whole family to enjoy the sweetness while also maintaining good health.

Jiajie Biomedical announced that to celebrate the launch of its new products, from now until January 31st, Jiajie Biomedical's e-commerce platform is offering a special introductory price of NT$390 per box for "Calendula Lutein Filled Gummies" and "Probiotic Filled Gummies," or NT$750 for a two-flavor combo. Multiple purchases are also available at discounted prices. For more details, please visit the Jiajie Biomedical e-commerce platform at https://www.jiajie-mit.com/ or contact customer service at 0800-530-885.